Stocklytics Platform
IBRN
iShares Trust - iShares Neuroscience and Healthcare ETF
IBRN
$25.47arrow_drop_down0.09%-$0.02

Performance History

Chart placeholder
Key Stats
Open$25.49
Prev. Close$25.50
EPS-
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap-
PE Ratio-
LOWHIGH
Day Range25.47
25.49
52 Week Range19.08
26.90
Ratios
P/B Ratio-
Revenue-
Operating M. %-
Earnings-
Earnings Growth %-
EBITDA Margin %-
ROE %-
EPS-

About iShares Trust - iShares Neuroscience and Healthcare ETF (IBRN)

The iShares Trust - iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that focuses on investments in the neuroscience and healthcare sector. As an ETF, IBRN offers investors the opportunity to gain exposure to a diversified portfolio of companies in this industry. The fund aims to track the performance of the S&P Kensho New Economies Composite Index, which includes companies involved in neuroscience research, healthcare technology, biotechnology, and pharmaceuticals. By investing in IBRN, investors can potentially benefit from the advancements and innovations in the neuroscience and healthcare field.
The price history of IBRN reflects the performance of the underlying index. Investors can track the historical prices of the ETF to analyze its past performance and gain insights into potential future trends. It is important to note that past performance does not guarantee future results, and investors should carefully consider their investment objectives and risk tolerance before investing in IBRN.
Sector
Industry
CEO
Headquarters
Employees
0
Exchange
NYSE

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

add iShares Trust - iShares Neuroscience and Healthcare ETF to watchlist

Keep an eye on iShares Trust - iShares Neuroscience and Healthcare ETF

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media